Clinical experience with a new catheter for His bundle ablation.
Eleven patients aged 33-66 years were referred for treatment of refractory supraventricular arrhythmias. Each patient had failed to respond to medical treatment. One patient had a paroxysmal atrial flutter with a rapid ventricular response. Six patients had a chronic atrial fibrillation. Two others had a supraventricular tachycardia due to reentry in the atrioventricular (AV) node, and two patients suffered from circus movement tachycardia using a concealed left free wall accessory pathway. A specially built United States Catheter and Instruments (USCI) women Dacron polyurethane electrode catheter (bipolar 8F with an internal lumen, 90 A, 5,000 V, 5.5 omega) was positioned in the His bundle area to record unipolar large atrial and His signals. When the maximal ratio low right atrium/His spike was recorded, the pole was connected to the output of a standard defibrillator. A shock of 200-250 J was delivered through this pole. Ten patients developed complete AV block (CAVB) immediately. After 72 hours, these patients were implanted with a rate-responsive pacemaker. The procedure was without side effects. Nine patients remain in CAVB after 3-17 months; in one case AV conduction resumed but the patient is free of arrhythmia. Another patient needed a second catheter ablation after 1 month.
Nzayinambaho
K
K
Service de Cardiologie, Université de Liège, Belgium.
Waleffe
A
A
Rodriquez
L M
LM
Kulbertus
H
H
D000328:Adult; D002036:Bundle of His / Q000601:surgery*; D004564:Electrocoagulation / Q000295:instrumentation*; D005260:Female; D006327:Heart Block / Q000209:etiology; D006329:Heart Conduction System / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011093:Polyethylene Terephthalates; D013617:Tachycardia, Supraventricular / Q000601:surgery*
D011093:Polyethylene Terephthalates